Koie T, Ohyama C, Makiyama K, Shimazui T, Miyagawa T, Mizutani K, Tsuchiya T, Kato T, Nakane K. Utility of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion for Muscle-Invasive Bladder Cancer. Int J Urol. 2019;26(3):334-340.
Hamano I, Hatakeyama S, Yamamoto H, Fujita T, Murakami R, Shimada M, Imai A, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Saitoh H, Suzuki T, Tomita H, Ohyama C. Impact of Distance Between Donor and Recipient Hospitals on Cadaveric Kidney Transplantation Outcomes.
Clin Exp Nephrol. 2019;23(6):807-813.
Iwamoto H, Morizane S, Koie T, Shiroki R, Kawakita M, Gondo T, Matsumoto K, Habuchi T, Sunada H, Endo Y, Noma H, Takenaka A, Kanayama H
Peri-operative Efficacy and Long-Term Survival Benefit of Robotic-Assisted Radical Cystectomy in Septuagenarian Patients Compared With Younger Patients: A Nationwide Multi-Institutional Study in Japan.
Int J Clin Oncol. 2019;24(12):1588-1595.
Yoneyama T, Tobisawa Y, Kaneko T, Kaya T, Hatakeyama S, Mori K, Sutoh Yoneyama M, Okubo T, Mitsuzuka K, Duivenvoorden W, Pinthus JH, Hashimoto Y, Ito A, Koie T, Suda Y, Gardiner RA, Ohyama C
Clinical Significance of the LacdiNAc-glycosylated Prostate-Specific Antigen Assay for Prostate Cancer Detection. Cancer Sci. 2019;110(8):2573-2589.
Kubota Y, Hatakeyama S, Hashimoto T, Fujita N, Okamoto T, Suzuki Y, Yamamoto H, Imai A, Yoneyama T, Hashimoto Y, Koie T, Ohyama C
Robot‐assisted radical cystectomy in a patient with muscle‐invasive bladder cancer following radiotherapy for prostate cancer.
IJU Case Reports. 2019;2(4):236-239.
Kido K, Hatakeyama S, Imai A, Yamamoto H, Tobisawa Y, Yoneyama T, Yoneyama T, Hashimoto Y, Koie T, Nakaji S, Ohyama C
Sleep Disturbance Has a Higher Impact on General and Mental Quality of LifeReduction Than Nocturia: Results From the Community Health Survey in Japan. Eur Urol Focus. 2019 Nov;5(6):1120-1126
Tsuchiya T, Imanaka K, Iwaki Y, Oyama R, Hashine K, Yamaguchi A, Uemura H
An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol. 2019, 24(12):1596-1604.
Mizutani K, Horie K, Kato T, Nakane K, Kawakami K, Fujita Y, Ito M
Serum PD-1 levels measured by ELISA using Nivolumab increased in advanced RCC patients: novel approach to develop companion diagnostics for antibody therapy.
J Cancer Res Clin Oncol
2019;145(6):1661-1663
Mizutani K, Kawakami K, Horie K, Fujita Y, Kameyama K, Kato T, Nakane K,
Tsuchiya T, Yasuda M, Masunaga K, Kasuya Y, Masuda Y, Deguchi T, Koie T,
Ito M
Urinary exosome as a potential biomarker for urinary tract nfection.
Cell Microbiol. 2019 Jul;21(7)
Yamada Y, Ohno Y, Kato Y, Kobayashi R, Hayashi H, Miyahara S, Nakane K,
Mizutani K, Yokoi S, Fujii H, Iihara H, Ishihara T, Deguchi T, Sugiyama T, Suzuki A
Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinoma.
Cancer Chemother Pharmacol.
2019;84(5):987-992
Nakane K，Muramatsu Y，Iinuma K，Mizutani K，Makiyama K，Koie T
Utility technique of a totally intracorporeal ileal conduit afUter robot‐
assisted radical cystectomy
Int Urol 2019;26(11):1083-1084
Horie K, Tsuchiya T, Iinuma K, Maekawa Y, Nakane K, Kato T, Mizutani K, Koie T. Risk factorsand incidence of malignant neoplasms after kidney transplantation at a single institution in Japan.
Clin Exp Nephrol 2019;23(11):1323-1330.
Iinuma K, Mizutani K, Kato T, Nakane K, Tanaka H, Nakano M, Matsuo M,
Insertion During Permanent iodine-125 Implant Brachytherapy: A Case Report
Mol Clin Oncol 11(6):580-582, 2019
Kodama H, Koie T, Oikawa M, Narita T, Tanaka T, Noro D, Iwamura H, Tobisawa Y, Yoneyama T, Hashimoto Y, Ohyama C.
Castration-resistant prostate cancer without metastasis at presentation may achieve cancer-specific survival in patients who underwent prior radical prostatectomy.
Int Urol Nephrol. 2020;52:671-679.
Oikawa M, Tanaka T, Narita T, Noro D, Iwamura H, Tobisawa Y, Yoneyama T, Kodama H, Hashimoto Y, Koie T, Ohyama C
Impact of the Proportion of Biopsy Positive Core in Predicting Biochemical Recurrence in Patients with Pathological Pt2 and Negative Resection Margin Status after Radical Prostatectomy.
Pathol Oncol Res. 2020;26:2115-2121.
Tomita Y, Naito S, Sassa N, Takahashi A, Kondo T, Koie T, Obara W, Kobayashi Y, Teishima J, Takahashi M, Matsuyama H, Ueda T, Yamaguchi K, Kishida T, Shiroki R, Saika T, Shinohara N, Oya M, Kanayama HO.
Sunitinib Versus Sorafenib as Initial Targeted Therapy for mCC-RCC With Favorable/Intermediate Risk: Multicenter Randomized Trial CROSS-J-RCC. Clin Genitourin Cancer. 2020;18:e374-e385.
Koie T, Hashimoto Y, Imai A, Yoneyama T, Tobisawa Y, Tanaka T, Noro D,
Oikawa Suzuki T.
Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution.
Int Urol Nephrol. 2021;53:275-280.
IJU Case Rep. 2020;4:26-28.
Nakane K, Enomoto T, Hishida S, Tomioka M, Taniguchi T, Kato D, Takai M,
Iinuma K, Muramatsu Maekawa Y, Horie K, Mizutani K, Tsuchiya T, Yokoi S, Koie T.
The Utility and Efficacy of Laparoscopic Radical Cystectomy in Patients with Muscle-
Invasive Bladder Cancer at a Single Institution.
Urol Int. 2020;104:573-579.
Maekawa-Muramathu Y, Horie K, Iinuma K, Takai M, Ohzawa K, Tsuchiya T, Kato D, Taniguchi T, Ito H, Hishida S, Nakane K, Mizutani K, Koie T, Kato T
Effect of Posttransplant Diabetes Mellitus on Graft Loss After Living-Donor Kidney Transplant at a Single Institution.
Transplant Proc. 2020;52:162-168.
Iinuma K, Nakano M, Kato T, Kato D, Takai M, Maekawa Y, Nakane K, Mizutani K,
Tsuchiya T, Ishihara T, Ito M, Matsuo M, Koie T
Assessment of Long-term Changes in Lower Urinary Tract Symptoms in Patients With
Prostate Cancer Who Underwent Low-dose-rate Prostate Brachytherapy.
Urology. Aug; 142:213-220. 2020.
Takai M, Kato S, Nakano M, Fujimoto S, Iinuma K, Ishida T, Taniguchi M, Tamaki M,
Uno M, Takahashi Y, Komeda H, Koie T.
Efficacy of cabazitaxel and the influence of clinical factors on the overall survival of
patients with castration-resistant prostate cancer: A local experience of a multicenter
retrospective study.
Asia Pac J Clin Oncol. 2021;28:1402-1411.
Kato D, Nakane K, Enomoto T, Tomioka M, Nakai C, Takai M, Iinuma K, Muramatsu
Maekawa Y, Mizutani K, Tsuchiya T, Yokoi S, Koie T.
The utility of laparoscopic partial nephrectomy with renal function preservation,
regardless of warm ischemia time, compared with laparoscopic radical nephrectomy.
Asian J Endosc Surg. 2021;14:386-393.
Horie K, Kawakami K, Fujita Y, Matsuda Y, Arai T, Suzui N, Miyazaki T, KoieT,
Mizutani K, Ito M
Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal
Cell Carcinoma with Advanced Clinicopathological Features.
Oncology. 2020;98:734-742.
Taniguchi T, Iinuma K, Kato D, Takai M, Maekawa YM, Nakane K, Mizutani K, Tsuchiya T, Nakano M, Kato T, Ito M, Kumano T, Matsuo M, Koie T
Predictive factors of rectal hemorrhage in patients with localized prostate cancer who underwent low-dose-rate brachytherapy.
Int J Clin Oncol. 2020;25:1711-1717
Tomioka M, Yoneyama T, Tobisawa Y, Kawase K, Nakai C, Takai M, Kato D, Iinuma K, Nakane K, Mizutani K, Hashimoto Y, Koie T.
Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer
Translational Andrology and Urology 2021 Mar;10(3):1192-1201.
Case Reports
Muramatsu-Maekawa Y, Taniguchi T, Ito H, Nakane K, Kato T, Tsuchiya T,
Miyazaki T, Koie T, Mizutani K
Pembrolizumab Treatment and Pathologic Therapeutic Evaluation for Granulocyte Colony-stimulating Factor-producing Bladder Cancer: A Case Report and Literature Review.
J Immunother. 2020;43:134-138. Urol Case Rep. 2020;31:101145.
Takai M, Kato D, Iinuma K, Maekawa YM, Nakane K, Tsuchiya T, Yokoi S, Koie T
Simultaneous pembrolizumab-induced myasthenia gravis and myocarditis in a patient with metastatic bladder cancer: A case report.
Koie T, Hashimoto Y, Suzuki Y, Hatayama Y, Kimura F
Leptomeningeal Metastases in a Patient with Castration-Resistant Prostate Cancer. Case Rep
Urol. 2020;2020:5627548.
Koie T, Hagiwara N, Yamada T, Kondo H, Ito H, Tomioka M, Kawashima K, Kato D, Iinuma K, Nakane K. Usefulness of robot-assisted radical prostatectomy in a patient with oligometastatic castration-resistant prostate cancer. IJU Case Rep. 2020;4:26-28.
Tomioka K, Koie T, et al.
A case of multiple metastatic sarcomatoid renal cell carcinoma with complete response to nivolumab.
Cancer Rep (Hoboken). 2021:e1356.
Tomioka M, Kawase M, Kato D, Takai M, Iinuma K, Horie K, Nakane K, Suzui N, Miyazaki T, Koie T.
Leptomeningeal Carcinomatosis in Urothelial Carcinoma of the Urinary Bladder: A Report of a Patient with a Fulminant Course Who Died of Cancer after Definitive Therapies
Case Reports in Urology 2021 Apr 30;2021:5543939
Koie T, Hashimoto Y, Imai A, Yoneyama T, Tobisawa Y, Tanaka T, Noro D, Oikawa M, Suzuki T. Long-term chronological changes in urination status of patients who underwent ileal neobladder reconstruction at a single institution. Int Urol Nephrol 2021;53:275-280.
Takai M, Kato S, Nakano M, Fujimoto S, Iinuma K, Ishida T, Taniguchi M, Tamaki M, Uno M, Takahashi Y, Komeda H, Koie T. Efficacy of cabazitaxel and the influence of clinical factors on the overall survival of patients with castration-resistant prostate cancer: A local experience of a multicenter retrospective study. Asia Pacif J Clin Oncol 2021;17:238-244.
Kato D, Nakane K, Enomoto T, Tomioka M, Nakai C, Takai M, Iinuma K, Muramatsu Maekawa Y, Mizutani K, Tsuchiya T, Yokoi S, Koie T. The utility of laparoscopic partial nephrectomy with renal function preservation, regardless of warm ischemia time, compared with laparoscopic radical nephrectomy. Asisn J Rndosc Surg 2021;14:386-393.
Iinuma K, Yuhara K, Kotaka H, Ozawa K, Kato D, Takai M, Nakane K, Mizutani K, Tsuchiya T, Koie T. Preoperative predictive factors of carcinoma in situ in the normal-appearing mucosa in patients who underwent an initial transurethral resection for non-muscle-invasive bladder cancer under white light cystoscopy. Cancer Rep (Hoboken) 2021;4:e1321.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators (Koie T). Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma. N Engl J Med 2021;384:1289-1300.
Tomioka M, Nakane K, Ozawa K, Iinuma K, Suzui N, Miyazaki T, Koie T. A case of multiple metastatic sarcomatoid renal cell carcinoma with complete response to nivolumab. Cancer Rep (Hoboken) 2021;4:e1356.
Mizutani K, Ito T, Takahara K, Ando R, Ishihara T, Yasui T, Shiroki R, Miyake H, Koie T. Frequency of pre-treatment may not increase the immune-related adverse events of RCC patients treated with nivolumab. Medicine (Baltimore) 2021;100:e25402.
Kato D, Ozawa K, Takeuchi S, Kawase M, Kawase K, Nakai C, Takai M, Iinuma K, Nakane K, Kato H, Matsuo M, Suzui N, Miyazaki T, Koie T. The Utility of Combined Target and Systematic Prostate Biopsies in the Diagnosis of Clinically Significant Prostate Cancer Using Prostate Imaging Reporting and Data System Version 2 Based on Biparametric Magnetic Resonance Imaging. Curr Oncol 2021;28:1294-1301
Tomioka M, Yoneyama T, Tobisawa Y, Kawase K, Nakai C, Takai M, Kato D, Iinuma K, Nakane K, Mizutani K, Hashimoto Y, Koie T. Ghrelin after chemotherapy as a prognostic predictor of progression-free survival in patients with muscle-invasive bladder cancer. Trans Androl Urol 2021;10:1192-1201
Muramatsu-Maekawa Y, Kawakami K, Fujita Y, Takai M, Kato D, Nakane K, Kato T, Tsuchiya T, Koie T, Miura Y, Ito M, Mizutani K. Profiling of Serum Extracellular Vesicles Reveals miRNA-4525 as a Potential Biomarker for Advanced Renal Cell Carcinoma. Cancer Genomics Proteomics 2021;18:253-259.
Hishida S, Kawakami K, Fujita Y, Kato T, Takai M, Iinuma K, Nakane K, Tsuchiya T, Koie T, Miura Y, Ito M, Mizutani K. Proteomic analysis of extracellular vesicles identified PI3K pathway as a potential therapeutic target for cabazitaxel-resistant prostate cancer. Prostate 2021;81:592-602.
Iinuma K, Kameyama K, Kawada K, Fujimoto S, Takagi K, Nagai S, Ito H, Ishida T, Kawase M, Kawase K, Nakai C, Kato D, Takai M, Nakane K, Koie T. Efficacy and Safety of Nivolumab and Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study. Curr Oncol 2021;28:1402-1411.
Iinuma K, Kawakami K, Mizutani K, Fujita Y, Yamaguchi T, Ito M, Kumano T, Matsuo M, Nakano M, Koie T, Ito M, Kato T. miRNA-93 in Serum Extracellular Vesicles Before and After Low Dose Rate Prostate Brachytherapy. Anticancer Res 2021;41:2411-2418.
Tomioka M, Kawase M, Kato D, Takai M, Iinuma K, Horie K, Nakane K, Suzui N, Miyazaki T, Koie T. Leptomeningeal Carcinomatosis in Urothelial Carcinoma of the Urinary Bladder: A Report of a Patient with a Fulminant Course Who Died of Cancer after Definitive Therapies. Case Rep Urol 2021;2021:5543939.
Matsuda Y, Narita S, Okubo T, Mitsuzuka K, Hatakeyama S, Koizumi A, Koie T, Kawamura S, Tochigi T, Ito A, Oyama C, Arai Y, Habuchi T. Impact of Nerve-Sparing Status on Positive Surgical Margin Location and Biochemical Recurrence in Patients with Prostate Cancer Post Radical Prostatectomy. Ann Surg Oncol 2021;28:5341-5348.
Kawakami K, Fujita Y, Kato T, Horie K, Koie T, Umezawa K, Tsumoto H, Miura Y, Katagiri Y, Miyazaki T, Ohsawa I, Mizutani K, Ito M. Diagnostic potential of serum extracellular vesicles expressing prostate-specific membrane antigen in urologic malignancies. Sci Rep 2021;11:15000.
Uno H, Taniguchi T, Seike K, Kato D, Takai M, Iinuma K, Horie K, Nakane K, Koie T. The accuracy of prostate cancer diagnosis in biopsy-naive patients using combined magnetic resonance imaging and transrectal ultrasound fusion-targeted prostate biopsy. Transl Androl Urol 2021;10:2982-2989.
Takai M, Kawakami K, Fujita Y, Kato T, Kato D, Iinuma K, Koie T, Ito M, Mizutani K. Kartogenin Inhibits Prostate Cancer Cell Growth Through Smad2 Activation and Decreases Androgen Receptor Nuclear Localization. Anticancer Res 2021;41:4753-47593
Seike K, Ishida T, Taniguchi T, Fujimoto S, Kato D, Takai M, Iinuma K, Nakane K, Uno H, Tamaki M, Komeda H, Koie T. Low Body Mass Index as a Predictive Factor for Postoperative Infectious Complications after Ureterorenoscopic Lithotripsy. Medicina (Kaunas) 2021;57:1100.
Kawase M, Nakane K, Namiki S, Takeuchi Y, Ueda S, Kawase K, Nakai C, Takeuchi S, Kato D, Takai M, Iinuma K, Fuwa M, Saigo C, Miyazaki T, Morita H, Koie T. A Case of Localized Prostate Cancer Associated with Polymyalgia Rheumatica with Marked Symptomatic Improvement after Robot-Assisted Radical Prostatectomy. Case Rep Urol 2021;2021:8026883.
Iinuma K, Enomoto T, Kawada K, Fujimoto S, Ishida T, Takagi K, Nagai S, Ito H, Kawase M, Nakai C, Kawase K, Kato D, Takai M, Nakane K, Kameyama K, Koie T. Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab. J Clin Med 2021;10:5325.
Takeuchi Y, Kato D, Nakane K, Kawase K, Takai M, Iinuma K, Saigo C, Miyazaki T, Koie T. Solitary Fibrous Tumor of the Prostate: A Case Report and Literature Review. Medicina (Kaunas) 2021;57:1152.
Takeuchi S, Nakane K, Saigo C, Miyazaki T, Koie T. A Case of Muscle-Invasive Bladder Cancer With Pelvic Lymph Node Involvement Treated With Pembrolizumab and Subsequent Radical Cystectomy and Maintained No Evidence of Disease After Surgery. Cureus 2021;13:e19375.
Kato s, Takai M, Iinuma K, Fujimoto S, Nakano M, Ishida T, Uno M, Tamaki M, Taniguchi M, Komeda H, Takahashi Y, Koie T. Sequential Docetaxel in ≥7 Cycles Followed by Cabazitaxel Improves Oncological Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer. The Scientific World Journal 2021;2021:8824140.
Nakane K, Enomoto T, Tomioka M, Taniguchi T, Kawase M, Kawase K, Kato D, Takai M, Iinuma K, Seike K, Hagiwara N, Uno H, Yuhara K, Koie T. Favorable surgical outcomes and perioperative complication rates after robotic radical cystectomy and intracorporeal urinary diversion at a single, low-volume center: Initial experience with 65 consecutive cases. World Journal of Clinical Surgery 2021;Issue 6:1-6.
